Literature DB >> 28241248

Value of Cardiovascular Magnetic Resonance Imaging in Noninvasive Risk Stratification in Tetralogy of Fallot.

Jouke P Bokma1, Koen C de Wilde2, Hubert W Vliegen3, Arie P van Dijk4, Joost P van Melle5, Folkert J Meijboom6, Aeilko H Zwinderman7, Maarten Groenink1, Barbara J M Mulder1, Berto J Bouma1.   

Abstract

Importance: Adults late after total correction of tetralogy of Fallot (TOF) are at risk for major complications. Cardiovascular magnetic resonance (CMR) imaging is recommended to quantify right ventricular (RV) and left ventricular (LV) function. However, a commonly used risk model by Khairy et al requires invasive investigations and lacks CMR imaging to identify high-risk patients. Objective: To implement CMR imaging in noninvasive risk stratification to predict major adverse clinical outcomes. Design, Setting, and Participants: This multicenter study included 575 adult patients with TOF (4.083 patient-years at risk) from a prospective nationwide registry in whom CMR was performed. This study involved 5 tertiary referral centers with a specialized adult congenital heart disease unit. Multivariable Cox hazards regression analysis was performed to determine factors associated with the primary end point. The CMR variables were combined with the noninvasive components of the Khairy et al risk model, and the C statistic of the final noninvasive risk model was determined using bootstrap sampling. The data analysis was conducted from January to December 2016. Main Outcomes and Measures: The composite primary outcome was defined as all-cause mortality or ventricular arrhythmia, defined as aborted cardiac arrest or documented ventricular fibrillation and ventricular tachycardia (lasting ≥30 seconds or recurrent symptomatic).
Results: Of the 575 patients with TOF, 57% were male, and the mean (SD) age was 31 (11) years. During a mean (SD) follow-up of 7.1 (3.5) years, the primary composite end point occurred in 35 patients, including all-cause mortality in 13 patients. Mean (SD) RV ejection fraction (EF) was 44% (10%), and mean (SD) LV EF was 53% (8%). There was a correlation between RV EF and LV EF (R, 0.36; 95% CI, 0.29-0.44; P < .001). Optimal thresholds for ventricular function (RV EF <30%: hazard ratio, 3.90; 95% CI, 1.84-8.26; P < .001 and LV EF <45%: hazard ratio, 3.23; 95% CI, 1.57-6.65; P = .001) were independently predictive in multivariable analysis. Both thresholds were included in a point-based noninvasive risk model (C statistic, 0.75; 95% CI, 0.63-0.85) and combined with the noninvasive components of the Khairy et al risk model. Conclusions and Relevance: In patients with repaired TOF, biventricular dysfunction on CMR imaging was associated with major adverse clinical outcomes. The quantified thresholds (RV EF <30% and LV EF <45%) may be implemented in noninvasive risk stratification.

Entities:  

Mesh:

Year:  2017        PMID: 28241248      PMCID: PMC5540000          DOI: 10.1001/jamacardio.2016.5818

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  15 in total

1.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

Authors:  Helmut Baumgartner; Philipp Bonhoeffer; Natasja M S De Groot; Fokko de Haan; John Erik Deanfield; Nazzareno Galie; Michael A Gatzoulis; Christa Gohlke-Baerwolf; Harald Kaemmerer; Philip Kilner; Folkert Meijboom; Barbara J M Mulder; Erwin Oechslin; Jose M Oliver; Alain Serraf; Andras Szatmari; Erik Thaulow; Pascal R Vouhe; Edmond Walma
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

2.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair.

Authors:  A L Knauth; K Gauvreau; A J Powell; M J Landzberg; E P Walsh; J E Lock; P J del Nido; T Geva
Journal:  Heart       Date:  2006-11-29       Impact factor: 5.994

3.  Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot.

Authors:  Gijsbert F L Kapel; Frédéric Sacher; Olaf M Dekkers; Masaya Watanabe; Nico A Blom; Jean-Benoît Thambo; Nicolas Derval; Martin J Schalij; Zakaria Jalal; Adrianus P Wijnmaalen; Katja Zeppenfeld
Journal:  Eur Heart J       Date:  2017-01-21       Impact factor: 29.983

4.  PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).

Authors:  Paul Khairy; George F Van Hare; Seshadri Balaji; Charles I Berul; Frank Cecchin; Mitchell I Cohen; Curt J Daniels; Barbara J Deal; Joseph A Dearani; Natasja de Groot; Anne M Dubin; Louise Harris; Jan Janousek; Ronald J Kanter; Peter P Karpawich; James C Perry; Stephen P Seslar; Maully J Shah; Michael J Silka; John K Triedman; Edward P Walsh; Carole A Warnes
Journal:  Heart Rhythm       Date:  2014-05-09       Impact factor: 6.343

5.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.

Authors:  M A Gatzoulis; S Balaji; S A Webber; S C Siu; J S Hokanson; C Poile; M Rosenthal; M Nakazawa; J H Moller; P C Gillette; G D Webb; A N Redington
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

6.  A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data.

Authors:  Hajime Uno; Lu Tian; Tianxi Cai; Isaac S Kohane; L J Wei
Journal:  Stat Med       Date:  2012-10-05       Impact factor: 2.373

7.  [National registry and DNA-bank of patients with congenital heart disease: the CONCOR-project].

Authors:  J W J Vriend; E T van der Velde; B J M Mulder
Journal:  Ned Tijdschr Geneeskd       Date:  2004-08-14

8.  Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot.

Authors:  Jouke P Bokma; Michiel M Winter; Thomas Oosterhof; Hubert W Vliegen; Arie P van Dijk; Mark G Hazekamp; Dave R Koolbergen; Maarten Groenink; Barbara J Mulder; Berto J Bouma
Journal:  Eur Heart J       Date:  2015-10-27       Impact factor: 29.983

9.  Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot.

Authors:  Rachel M Wald; Idith Haber; Ron Wald; Anne Marie Valente; Andrew J Powell; Tal Geva
Journal:  Circulation       Date:  2009-03-02       Impact factor: 29.690

10.  Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.

Authors:  Anne Marie Valente; Kimberlee Gauvreau; Gabriele Egidy Assenza; Sonya V Babu-Narayan; Jenna Schreier; Michael A Gatzoulis; Maarten Groenink; Ryo Inuzuka; Philip J Kilner; Zeliha Koyak; Michael J Landzberg; Barbara Mulder; Andrew J Powell; Rachel Wald; Tal Geva
Journal:  Heart       Date:  2013-10-31       Impact factor: 5.994

View more
  15 in total

1.  Detection of persistent systolic and diastolic abnormalities in asymptomatic pediatric repaired tetralogy of Fallot patients with preserved ejection fraction: a CMR feature tracking study.

Authors:  Rongzhen Ouyang; Shuang Leng; Aimin Sun; Qian Wang; Liwei Hu; Xiaodan Zhao; Qin Yan; Ru-San Tan; Liang Zhong; Yumin Zhong
Journal:  Eur Radiol       Date:  2021-01-25       Impact factor: 5.315

Review 2.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 3.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

4.  A novel method for evaluating regional RV function in the adult congenital heart with low-dose CT and SQUEEZ processing.

Authors:  Francisco J Contijoch; Daniel W Groves; Zhennong Chen; Marcus Y Chen; Elliot R McVeigh
Journal:  Int J Cardiol       Date:  2017-09-29       Impact factor: 4.164

5.  Disturbed left and right ventricular kinetic energy in patients with repaired tetralogy of Fallot: pathophysiological insights using 4D-flow MRI.

Authors:  Pia Sjöberg; Sebastian Bidhult; Jelena Bock; Einar Heiberg; Håkan Arheden; Ronny Gustafsson; Shahab Nozohoor; Marcus Carlsson
Journal:  Eur Radiol       Date:  2018-04-17       Impact factor: 5.315

6.  Determinants of Left Ventricular Dysfunction and Remodeling in Patients With Corrected Tetralogy of Fallot.

Authors:  Ana Cristina Andrade; Michael Jerosch-Herold; Philip Wegner; Dominik Daniel Gabbert; Inga Voges; Minh Pham; Ravi Shah; Jürgen Hedderich; Hans-Heiner Kramer; Carsten Rickers
Journal:  J Am Heart Assoc       Date:  2019-08-31       Impact factor: 5.501

7.  Tetralogy of Fallot or Pulmonary Atresia with Ventricular Septal Defect after the Age of 40 Years: A Single Center Study.

Authors:  Julia Hock; Laurent Schwall; Claudia Pujol; Alfred Hager; Renate Oberhoffer; Peter Ewert; Oktay Tutarel
Journal:  J Clin Med       Date:  2020-05-19       Impact factor: 4.241

8.  The applications and potential limitations of right ventricular volumes as surrogate marker in tetralogy of fallot.

Authors:  Alexander C Egbe; Keerthana Banala; Rahul Vojjini; Karim Osman; Arslan Afzal; Vaibhav Jain; Sahith Thotamgari; Naser M Ammash
Journal:  Int J Cardiol Heart Vasc       Date:  2019-11-14

9.  Impact of Inferior Venae Cava Assessment in Tetralogy of Fallot.

Authors:  Alexander C Egbe; Rahul Vojjini; Patricia A Pellikka; Crystal Bonnichsen; Jason H Anderson; Nathaniel W Taggart
Journal:  CJC Open       Date:  2020-02-24

10.  Prognostic Implications of Left Ventricular Cardiomyopathy in Adults With Tetralogy of Fallot.

Authors:  Alexander C Egbe; Patricia A Pellikka; Arslan Afzal; Vaibhav Jain; Sahith Thotamgari; William R Miranda; Heidi M Connolly
Journal:  CJC Open       Date:  2019-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.